Qiuxiang Wang

735 total citations
21 papers, 270 citations indexed

About

Qiuxiang Wang is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Qiuxiang Wang has authored 21 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Surgery. Recurrent topics in Qiuxiang Wang's work include Ocular Surface and Contact Lens (4 papers), Advanced Drug Delivery Systems (4 papers) and COVID-19 and healthcare impacts (2 papers). Qiuxiang Wang is often cited by papers focused on Ocular Surface and Contact Lens (4 papers), Advanced Drug Delivery Systems (4 papers) and COVID-19 and healthcare impacts (2 papers). Qiuxiang Wang collaborates with scholars based in China and United States. Qiuxiang Wang's co-authors include Guihua Fang, Bo Tang, Xuewen Yang, Aiwen Zhang, Xia Mao, Qian Yu, Yicheng Zhang, Jianfeng Zhou, Chunrui Li and Guowei Zhang and has published in prestigious journals such as Blood, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Qiuxiang Wang

15 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiuxiang Wang China 8 75 67 64 63 63 21 270
Jingyi Wang China 12 41 0.5× 193 2.9× 43 0.7× 76 1.2× 28 0.4× 37 434
Giulia Chindamo Italy 9 80 1.1× 91 1.4× 41 0.6× 30 0.5× 39 0.6× 16 314
Sarath K. Yandrapu United States 5 178 2.4× 124 1.9× 44 0.7× 11 0.2× 42 0.7× 6 306
Pritish Kumar Panda India 10 111 1.5× 152 2.3× 37 0.6× 22 0.3× 30 0.5× 18 402
Zhuping Xu China 13 15 0.2× 128 1.9× 52 0.8× 37 0.6× 28 0.4× 35 384
Paraskevi E. Kolovou United States 10 76 1.0× 91 1.4× 192 3.0× 22 0.3× 181 2.9× 11 398
Shallu Kutlehria United States 12 103 1.4× 114 1.7× 41 0.6× 39 0.6× 63 1.0× 16 398
Christian Zevallos‐Delgado United States 10 24 0.3× 122 1.8× 27 0.4× 44 0.7× 76 1.2× 30 278
Gyan Prakash Mishra United States 12 172 2.3× 169 2.5× 136 2.1× 52 0.8× 65 1.0× 21 558
Michael G. Lancina United States 9 106 1.4× 112 1.7× 84 1.3× 11 0.2× 61 1.0× 10 358

Countries citing papers authored by Qiuxiang Wang

Since Specialization
Citations

This map shows the geographic impact of Qiuxiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiuxiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiuxiang Wang more than expected).

Fields of papers citing papers by Qiuxiang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiuxiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiuxiang Wang. The network helps show where Qiuxiang Wang may publish in the future.

Co-authorship network of co-authors of Qiuxiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qiuxiang Wang. A scholar is included among the top collaborators of Qiuxiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiuxiang Wang. Qiuxiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qiuxiang, Guozheng Zhang, Min Hu, et al.. (2025). M‐site dependent terahertz intrinsic absorption in MXenes. InfoMat. 7(4). 2 indexed citations
3.
Zhang, Tianze, Peiyu Cao, Qiuxiang Wang, et al.. (2025). Pure oxygen terminated MXenes prepared by NaOH/NaI eutectic molten salt. Fundamental Research.
4.
Wang, Qiuxiang, et al.. (2025). Effect of obesity on perioperative outcomes following lung cancer surgery: a systematic review and meta-analysis. Frontiers in Oncology. 15. 1600503–1600503.
5.
Xu, Bin, et al.. (2025). RGS14 promotes the progression of hepatocellular carcinoma by activating the cAMP/PKA/CREB signaling pathway. Journal of Cancer Research and Clinical Oncology. 151(5). 153–153.
6.
Fang, Guihua, Rongrong Zhao, Lu Zhu, et al.. (2025). Nanoemulsion-based pseudopolyrotaxane hydrogel for enhanced corneal bioavailability and treatment of corneal inflammation. Journal of Controlled Release. 379. 14–29. 6 indexed citations
8.
Sun, Fen, et al.. (2024). The impact of salt consumption on cardiometabolic and cognitive health in aged female rats. Scientific Reports. 14(1). 25363–25363.
9.
Wang, Qiuxiang, et al.. (2023). The safety of colorectal cancer surgery during the COVID-19: a systematic review and meta-analysis. Frontiers in Oncology. 13. 1163333–1163333. 1 indexed citations
10.
Wang, Qiuxiang, et al.. (2023). Effect of polyphenol compounds onHelicobacter pylorieradication: a systematic review with meta-analysis. BMJ Open. 13(1). e062932–e062932. 12 indexed citations
11.
Li, Yilin, et al.. (2023). Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma. Journal of Gastrointestinal Oncology. 14(3). 1392–1411. 3 indexed citations
12.
Wang, Qiuxiang, et al.. (2022). Traditional Chinese Medicine Regulates Th17/Treg Balance in Treating Inflammatory Bowel Disease. Evidence-based Complementary and Alternative Medicine. 2022. 1–13. 8 indexed citations
13.
Yuan, Lei, et al.. (2022). Association of inflammatory bowel disease with suicidal ideation, suicide attempts, and suicide: A systematic review and meta-analysis. Journal of Psychosomatic Research. 160. 110983–110983. 14 indexed citations
14.
Fang, Guihua, Xuewen Yang, Qiuxiang Wang, Aiwen Zhang, & Bo Tang. (2021). Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases. Materials Science and Engineering C. 127. 112212–112212. 99 indexed citations
15.
Fang, Guihua, Qiuxiang Wang, Xuewen Yang, et al.. (2021). γ-Cyclodextrin-based polypseudorotaxane hydrogels for ophthalmic delivery of flurbiprofen to treat anterior uveitis. Carbohydrate Polymers. 277. 118889–118889. 37 indexed citations
16.
Fang, Guihua, Qiuxiang Wang, Xuewen Yang, et al.. (2021). Vesicular phospholipid gels as topical ocular delivery system for treatment of anterior uveitis. Colloids and Surfaces A Physicochemical and Engineering Aspects. 627. 127187–127187. 7 indexed citations
17.
Xiong, Meng, Yangyang Li, Jin Qian, et al.. (2020). Chitosan oligosaccharide combined with running benefited the immune status of rats. International Immunopharmacology. 88. 106915–106915. 5 indexed citations
18.
Xu, Jinhuan, Qiuxiang Wang, Hao Xu, et al.. (2018). Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma. Journal of Hematology & Oncology. 11(1). 128–128. 40 indexed citations
19.
Li, Chunrui, Qiuxiang Wang, Hui Zhu, et al.. (2018). T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies. Blood. 132(Supplement 1). 1013–1013. 33 indexed citations
20.
Cao, Hui, Zongyun Li, & Qiuxiang Wang. (2009). The progress of research on Drosophila innate immunity.. 46(2). 196–202. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026